Article Text
Abstract
Diabetes mellitus is a common condition associated with numerous complications and comorbidities. The diabetes spectrum includes type 1, type 2 and other forms of diabetes, which may be associated with medical therapies and genetic factors. Type 2 diabetes is managed with lifestyle, oral therapies, non-insulin-based injectables and subsequently insulin. Type 1 diabetes requires insulin from the time of diagnosis. In recent years, there have been considerable developments in the therapies available to treat type 2 diabetes and some of these also afford cardiorenal protection. This review summarises the nature, complications and therapeutic advances in the field of diabetes and provides a concise review for neurologists. Managing diabetes optimally prevents complications and all medical specialties need a basic understanding of the principles involved in diabetes care.
- diabetes mellitus
Data availability statement
No data are available.
Statistics from Altmetric.com
Data availability statement
No data are available.
Footnotes
Contributors All authors have contributed to the preparation of the manuscript.
Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.
Competing interests None declared.
Provenance and peer review Commissioned; externally reviewed by Gareth Llewelyn, Gwent, UK, Suzanne Phillips, Gloucester, UK and Martin Sadler, Plymouth, UK.
Linked Articles
- Highlights from this issue
Read the full text or download the PDF:
Other content recommended for you
- New advances in type 1 diabetes
- Current management of diabetes mellitus and future directions in care
- Protocol for a randomised controlled trial of the effect of dapagliflozin, metformin and exercise on glycaemic variability, body composition and cardiovascular risk in prediabetes (the PRE-D Trial)
- Advances in the management of diabetes: new devices for type 1 diabetes
- Novel therapies for diabetes mellitus in pregnancy
- Advances in the management of type 2 diabetes in adults
- Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA/EASD consensus
- Diabetic ketoacidosis with SGLT2 inhibitors
- HbA1c variability in adults with type 1 diabetes on continuous subcutaneous insulin infusion (CSII) therapy compared to multiple daily injection (MDI) treatment
- Effect of dapagliflozin on 24-hour glycemic variables in Japanese patients with type 2 diabetes mellitus receiving basal insulin supported oral therapy (DBOT): a multicenter, randomized, open-label, parallel-group study